Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir for Recurrent HCV in Liver Transplant Recipients
NCT01592006Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Apr 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telaprevir in hepatitis C (HCV), sponsored by University of Chicago. Started Apr 2012; status: terminated.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01592006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01592006.